RS34954997 Unknown gene
Upload your DNA to see your genotype for this variant.
GWAS Studies (20)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| Tubulin-specific chaperone A levels (TBCA.12501.10.3) | CTTCG | OR: 1.15 | 3E-621 | PubMed |
| Triglyceride levels | CTTCG | OR: 0.13 | 2E-113 | PubMed |
| Interferon-induced protein with tetratricopeptide repeats 2 levels | — | OR: 0.28 | 2E-66 | PubMed |
| Calcium-activated chloride channel regulator 2 levels | — | OR: 0.26 | 2E-64 | PubMed |
| Cholesteryl Esters to Total Lipids in Large LDL percentage | CTTCG | β: 0.055 | 9E-51 | PubMed |
| Neuralized-like protein 4 levels | — | OR: 0.23 | 1E-46 | PubMed |
| RAC-beta serine/threonine-protein kinase levels | — | OR: 0.21 | 3E-41 | PubMed |
| SMPD1 protein levels | CTTCG | β: 0.074 | 5E-41 | PubMed |
| CPQ protein levels | CTTCG | β: 0.072 | 8E-36 | PubMed |
| Average diameter for VLDL particles | C | β: 0.056 | 3E-34 | PubMed |
| SH2 domain-containing protein 3C levels | — | OR: 0.18 | 7E-31 | PubMed |
| Total triglycerides levels | C | β: 0.054 | 2E-30 | PubMed |
| Protocadherin beta-10 levels | — | OR: 0.18 | 4E-30 | PubMed |
| Triglyceride levels | — | — | 1E-26 | PubMed |
| HLA class II histocompatibility antigen, DR beta 3 chain levels | — | OR: 0.17 | 1E-25 | PubMed |
| Uncharacterized protein C14orf93 levels | — | OR: 0.17 | 4E-25 | PubMed |
| TOM1-like protein 1 levels | — | OR: 0.16 | 5E-25 | PubMed |
| Triglyceride levels in VLDL | C | β: 0.048 | 9E-25 | PubMed |
| Triglyceride levels in very large VLDL | C | β: 0.048 | 1E-24 | PubMed |
| Total lipid levels in very large VLDL | C | β: 0.044 | 3E-21 | PubMed |